Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Moraleda

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
British Journal of Haematology|September 13, 2001
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignanciesS Brunet, A Urbano-Ispizua, E Ojeda, et al.
Bone Marrow Transplantation|September 26, 2001
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantationA Urbano-Ispizua, S Brunet, C Solano, et al.
Sangre|April 1, 1997
[Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma]J García Laraña, J Díaz Mediavilla, R Martínez, et al.
British Journal of Haematology|June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple MyelomaJ J Lahuerta, J Martinez-Lopez, C Grande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupM D Caballero, J A Pérez-Simón, A Iriondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative GroupA Sureda, R Arranz, A Iriondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseA Sureda, M Constans, A Iriondo, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?J F San Miguel, J J Lahuerta, R García-Sanz, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
British Journal of Haematology|September 13, 2001
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignanciesS Brunet, A Urbano-Ispizua, E Ojeda, et al.
Bone Marrow Transplantation|September 26, 2001
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantationA Urbano-Ispizua, S Brunet, C Solano, et al.
Sangre|April 1, 1997
[Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma]J García Laraña, J Díaz Mediavilla, R Martínez, et al.
British Journal of Haematology|June 10, 2000
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple MyelomaJ J Lahuerta, J Martinez-Lopez, C Grande, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupM D Caballero, J A Pérez-Simón, A Iriondo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative GroupA Sureda, R Arranz, A Iriondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2005
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseA Sureda, M Constans, A Iriondo, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?J F San Miguel, J J Lahuerta, R García-Sanz, et al.
Pageof 10